Blue Cross Complete of Michigan does cover Wegovy, but under tight limits that took effect January 1, 2026. For weight management, you generally need a BMI of 40 or higher, documented failure of other weight-loss treatments, and a prescriber attestation that Wegovy is being used to avoid bariatric surgery. Coverage is broader if you have certain qualifying medical conditions such as established cardiovascular disease, severe liver disease, or type 2 diabetes.
Who Qualifies for Wegovy Coverage
Blue Cross Complete follows the statewide Medicaid criteria that the Michigan Department of Health and Human Services issued in policy bulletin L 25-73 on December 8, 2025.1Michigan MDHHS. Numbered Letter L 25-73 Pharmacy Drug Coverage for Treatment of Obesity Wegovy is now on non-preferred status on the state’s Single Preferred Drug List as of February 1, 2026.2Blue Cross Complete. Formulary Change Update
To get Wegovy approved for weight management, you must meet all three of these conditions:
- A BMI of 40 or greater (morbid obesity).
- Documented trial and failure of other clinically appropriate weight-loss interventions, including the preferred anti-obesity medications phentermine and Qsymia (phentermine with topiramate).3University of Michigan Medical Research. Expert Q&A Michigan Medicaids New Limits GLP-1 Weight Management Medications
- A prescriber attestation that Wegovy is being used as a measure to avoid higher-cost bariatric surgery.1Michigan MDHHS. Numbered Letter L 25-73 Pharmacy Drug Coverage for Treatment of Obesity
Those obesity-specific hurdles do not apply if you need the drug for other reasons. Wegovy remains covered for members with established cardiovascular disease, severe liver disease, or type 2 diabetes.3University of Michigan Medical Research. Expert Q&A Michigan Medicaids New Limits GLP-1 Weight Management Medications Separate prior authorization criteria from Prime Therapeutics, the state’s pharmacy benefit manager, govern conditions like cardiovascular risk reduction and metabolic dysfunction-associated steatohepatitis.4Prime Therapeutics. Michigan Medicaid Clinical and PDL PA Criteria Sleep apnea is also still covered, under its own criteria.5CBS News Detroit. Michigan Medicaid Weight Loss Drugs Diabetes Morbid Obesity
How To Get Your Prescription Filled
Every Wegovy prescription needs prior authorization, no matter the diagnosis. Wegovy is a specialty medication, so your prescriber (not your pharmacist) submits the request. It can go through the Blue Cross Complete provider portal, by fax to 1-855-811-9326, or by phone at 1-888-989-0057.6Blue Cross Complete. Pharmacy Reference Guide
Once approved, the prescription is filled through Perform Specialty, Blue Cross Complete’s preferred specialty pharmacy, at 1-855-287-7888. Fills are limited to a 34-day supply. Blue Cross Complete members generally pay nothing for covered formulary medications; Medicaid fee-for-service members pay a $3 copay for non-preferred drugs like Wegovy.6Blue Cross Complete. Pharmacy Reference Guide1Michigan MDHHS. Numbered Letter L 25-73 Pharmacy Drug Coverage for Treatment of Obesity
If you were already taking Wegovy with an active prior authorization before January 1, 2026, that approval was honored for the rest of its six-month term. Renewals after it expires must meet the new, stricter criteria.7Priority Health. Medicaid GLP-1 Coverage Changes Effective January 1, 2026
If Your Wegovy Request Is Denied
Start by getting the written denial notice and reading the reason given. Some denials come down to missing documentation rather than a true coverage exclusion, and resubmission with better records can fix the problem.
You have 60 calendar days from the denial notice to file an internal appeal with Blue Cross Complete. Appeals go in writing to Member Appeals, Blue Cross Complete, P.O. Box 41789, North Charleston, SC 29423, or by fax to 1-855-737-9879. Standard reviews finish within 30 days. If delay could harm your health, you or your provider can request an expedited review, decided within 72 hours.8Blue Cross Complete. Grievance and Appeals Fact Sheet
If you want your current benefits to continue while the appeal is pending, you must ask within 10 calendar days of the denial notice. If the internal appeal is denied, two further routes exist: an external review through the Michigan Department of Insurance and Financial Services, filed within 127 calendar days of the denial notice, and a State Fair Hearing through the Michigan Administrative Hearing System, filed within 120 calendar days of the appeal decision.8Blue Cross Complete. Grievance and Appeals Fact Sheet
Strong appeals carry correct diagnosis codes matching your BMI category, records of every prior weight-loss attempt including the preferred medications, and documentation of comorbid conditions like cardiovascular disease, sleep apnea, or diabetes. If you have a condition that qualifies Wegovy under non-obesity criteria, making sure it is spelled out in the prior authorization can change the outcome.
Manufacturer Savings Programs Will Not Help
Novo Nordisk’s Wegovy savings card and self-pay pricing are not available to Medicaid members. Anyone covered by a government-funded plan, including Blue Cross Complete Medicaid, is excluded from the savings offer.9NovoCare. Wegovy Savings Offer The manufacturer’s “Check My Benefits” tool can still confirm what your plan will approve.10Wegovy. What To Pay for Wegovy
What Could Change Access Later
CMS launched the BALANCE model in December 2025, a five-year voluntary program that lets state Medicaid agencies sign supplemental rebate agreements for cheaper GLP-1 drugs. Medicaid access under BALANCE opened May 1, 2026, with states having until July 31, 2026 to apply. Participating states must use standardized coverage criteria and cannot be more restrictive than the model allows.11KFF. What To Know About the BALANCE Model for GLP-1s in Medicare and Medicaid Whether Michigan opts in is not yet decided; if it does, Wegovy access for Blue Cross Complete members could widen.